Mental Crisis Impacting Veterans
The Data on Prescription Psychedelics is Clear
In the evolving landscape of mental healthcare, a critical focus remains on the longevity and rigor of scientific research. It is essential to recognize that the move toward prescription psychedelics is not based on anecdotal evidence, but on a foundation of extensive, peer-reviewed clinical data that has been building for more than a decade. While […]
Mental Health: The Crisis We Can’t Ignore
Controlled Care: The Clinical Standard for FDA-Regulated Psychedelic Medicine
In the conversation surrounding next-generation mental health treatments, it is essential to separate outdated cultural perceptions from modern clinical reality. While some may express concern regarding the nature of these compounds, the focus of the Association for Prescription Psychedelics (APP) remains strictly on the rigorous, evidence-based medical model. Clinical evidence actually demonstrates a low potential […]
Medicine, Not a Movement: Why FDA Regulation is the Only Path Forward
When people hear the word “psychedelics,” their minds often jump to the counterculture movements of the 1960s or current debates surrounding recreational legalization. This often leads to the question: “Isn’t APP just trying to open the door to legalizing LSD?” The answer is a definitive no. The Association for Prescription Psychedelics (APP) is focused exclusively […]
The Human Stakes of Prescription Psychedelics
Every day in America, a tragic and silent crisis unfolds: between 17 and 44 veterans take their own lives. This is not merely a staggering statistic; it represents a catastrophic failure in our national standard of care for the men and women who have sacrificed the most for this country. While the mental health crisis […]
Researchers Map the ‘Neural Fingerprint’ Shared by All Major Psychedelics
A landmark meta-analysis in Nature Medicine has finally pinpointed how psychedelics reorganize the human brain. By analyzing over 500 brain scans, researchers discovered that substances like LSD and psilocybin “flatten” the brain’s natural hierarchy, sparking a massive surge in cross-talk between sensory and higher-order thinking networks. In a landmark moment for the field of psychedelic […]
A Breakthrough Within Reach: Why Trump/Kennedy Should Lead on Psychedelic Medicine
The Future of Biosynthesis: Engineering Tobacco for Multi-Compound Psychedelic Production
Is plant-based biosynthesis the key to the next generation of PTSD and depression treatments? Explore how scientists are utilizing the natural tryptophan abundance in tobacco to create a versatile manufacturing platform for rare hallucinogenic compounds, marking a massive milestone for the medical psychedelic industry. April 1, 2026 In a significant breakthrough published in Science, researchers […]
Louisiana Senate Approves Opioid Settlement Funding for Psychedelic Clinical Trials
The Louisiana Senate Health and Welfare Committee has approved a pioneering bill that would establish a state-led psychedelic-assisted therapy pilot program. Sponsored by Senator Patrick McMath (R), Senate Bill 43 proposes utilizing opioid settlement funds to finance clinical trials for substances with high therapeutic potential, including psilocybin and ibogaine. The legislation marks a significant shift […]